Iron metabolism by reticuloendothelial cells in vitro. Physical and chemical conditions, lipotrope deficiency, and acute inflammation.
D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology; D003035:Cobalt / Q000494:pharmacology; D003300:Copper / Q000494:pharmacology; D003545:Cysteine / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D003676:Deferoxamine / Q000494:pharmacology; D004140:Dinitrophenols / Q000494:pharmacology; D004492:Edetic Acid / Q000494:pharmacology; D005234:Fatty Liver / Q000378:metabolism; D005459:Fluorides / Q000494:pharmacology; D005632:Fructose / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D005978:Glutathione / Q000494:pharmacology; D006432:Hemochromatosis / Q000378:metabolism*; D007249:Inflammation / Q000378:metabolism*; D007461:Iodoacetates / Q000494:pharmacology; D007501:Iron / Q000378:metabolism*; D008082:Lipotropic Agents / Q000502:physiology*; D008103:Liver Cirrhosis / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism*; D008854:Microscopy, Electron; D011196:Potassium Permanganate / Q000494:pharmacology; D014176:Protein Biosynthesis; D011691:Puromycin / Q000494:pharmacology; D012313:RNA / Q000096:biosynthesis; D011817:Rabbits; D012503:Saponins / Q000494:pharmacology; D013395:Sucrose / Q000494:pharmacology; D013501:Surface-Active Agents / Q000494:pharmacology; D014168:Transferrin / Q000378:metabolism / Q000494:pharmacology; D014357:Trypsin / Q000494:pharmacology
D004140:Dinitrophenols; D007461:Iodoacetates; D008082:Lipotropic Agents; D012503:Saponins; D013501:Surface-Active Agents; D014168:Transferrin; D011196:Potassium Permanganate; D003609:Dactinomycin; D005632:Fructose; D003035:Cobalt; D011691:Puromycin; D013395:Sucrose; D012313:RNA; D003300:Copper; D004492:Edetic Acid; D007501:Iron; D014357:Trypsin; D005978:Glutathione; D005947:Glucose; D003676:Deferoxamine; D003545:Cysteine; D001205:Ascorbic Acid; D005459:Fluorides